Search - tctmd.com

Displaying 941 - 960 of 2392

Sort: Relevancy | Date

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Daily News

First High-Sensitivity Troponin Assay Finally Comes to the United States

Todd Neale

January 24, 2017

News Features

Quit This, Start That: How Common New Year’s Resolutions Impact the Heart

Shelley Wood

January 20, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Caitlin E. Cox

January 12, 2017

News Daily News

Noncardiac Chest Pain After Acute MI Common and ‘Just as Scary’: Why Cardiologists Should Care

Shelley Wood

January 12, 2017

News Features

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Michael O'Riordan

January 10, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Shelley Wood

January 04, 2017

News Daily News

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

Leah Lawrence

December 27, 2016

News Daily News

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

Todd Neale

December 19, 2016

News Daily News

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

Todd Neale

December 05, 2016

News Daily News

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

L.A. McKeown

December 02, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Presentation TCT 2016

Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction?

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

Advertisement

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

First High-Sensitivity Troponin Assay Finally Comes to the United States

Quit This, Start That: How Common New Year’s Resolutions Impact the Heart

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Noncardiac Chest Pain After Acute MI Common and ‘Just as Scary’: Why Cardiologists Should Care

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction?

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content